Skip to main content
MRCY
NASDAQ Manufacturing

Mercury Systems Reports Q2 FY26 Results, Discloses Internal Investigation, and Authorizes $200M Share Repurchase

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$88.56
Mkt Cap
$5.967B
52W Low
$39.89
52W High
$103.84
Market data snapshot near publication time

summarizeSummary

Mercury Systems reported improved Q2 FY26 adjusted earnings and revenue growth, but also disclosed a new internal investigation into product test results and authorized a $200 million share repurchase program.


check_boxKey Events

  • Q2 FY26 Financial Performance

    Net revenues increased 4.4% to $232.9 million, and net loss improved to $(15.1) million from $(17.6) million year-over-year. Adjusted EBITDA rose to $30.0 million from $22.0 million, and adjusted EPS increased to $0.16 from $0.07.

  • Internal Investigation Disclosed

    The company initiated an internal investigation in September 2025 into potentially inaccurately reported test results and certifications for subcontracts totaling approximately $15 million in revenue over 20 years, with potential for civil/criminal fines.

  • $200M Share Repurchase Program Authorized

    The Board authorized a new share repurchase program for up to $200 million. The company repurchased 221,510 shares for approximately $15.0 million in Q2 FY26 at an average cost of $67.70 per share, with $185.0 million remaining.

  • Legal Settlements Reached

    Resolved a dispute with the former CEO for a $5.0 million payment and agreed to a settlement in principle for a securities class action lawsuit for $32.5 million, which is expected to be covered by insurance.


auto_awesomeAnalysis

This 10-Q filing provides detailed financial results for Q2 FY26, which were partially pre-released in a recent 8-K. The filing reveals several new material developments, most notably an internal investigation into potentially inaccurately reported product test results for government subcontracts. While the customer has indicated no impact to system performance and agreed to modify specifications, the potential for civil or criminal fines makes this a significant risk factor. Additionally, the company authorized a new $200 million share repurchase program, signaling confidence in its valuation, and settled two major legal disputes. Despite improved adjusted earnings, a decline in operating and free cash flow for the six-month period presents a mixed financial picture. Investors should monitor the progress and outcome of the internal investigation closely.

At the time of this filing, MRCY was trading at $88.56 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6B. The 52-week trading range was $39.89 to $103.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MRCY - Latest Insights

MRCY
Mar 12, 2026, 5:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
MRCY
Mar 04, 2026, 9:46 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
MRCY
Mar 04, 2026, 9:45 PM EST
Filing Type: 4
Importance Score:
7
MRCY
Feb 03, 2026, 5:08 PM EST
Filing Type: 10-Q
Importance Score:
7
MRCY
Feb 03, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7